ResMed (ASX:RMD) is the dominant global supplier of medical equipment to treat obstructive sleep apnoea, an increasingly common affliction. Confidence in the outlook for the business dropped in mid-2023 with the arrival of the GLP-1 anti-obesity drugs ...









